Medlab still in limbo as talks continue with ‘interested parties’ by Steve Jones June 7, 2023April 30, 2024 The future of Medlab Clinical remains uncertain as the company continues to explore restructuring options. Shareholders […]
Medlab cancels studies and directors depart as ASX suspends shares by Steve Jones March 2, 2023April 30, 2024
Company news: LGP; Cann Global; Medcan; Incannex; Medlab; Emyria; RestoreMe; Releaf Group; Levin Health by Martin Lane and Steve Jones November 30, 2022April 29, 2024
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022April 29, 2024
Company news: Bod; Incannex; Medlab; Rua Bioscience; Emyria by Martin Lane October 20, 2022April 29, 2024
Company news: Cann Group; Medlab; ANTG; Medleaf; Ora Pharm; Creso Pharma; Greenfern Industries by Martin Lane June 30, 2022April 29, 2024
Company news: Cronos; ECS Botanics; Elixinol; Zelira; Medlab; Emyria; Creso; MGC Pharma; Botanix; Incannex by Martin Lane February 2, 2022April 29, 2024
Medlab offloads Australian nutraceutical arm to PharmaCare by Martin Lane October 20, 2021April 29, 2024